日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

His-MMDM: Multi-Domain and Multi-Omics Translation of Histopathological Images with Diffusion Models

His-MMDM:基于扩散模型的组织病理图像多域多组学转换

Li, Zhongxiao; Su, Tianqi; Zhang, Bin; Han, Wenkai; Zhang, Sibin; Sun, Guiyin; Cong, Yuwei; Chen, Xin; Qi, Jiping; Wang, Yujie; Zhao, Shiguang; Meng, Hongxue; Liang, Peng; Gao, Xin

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment

鉴定一种细胞衰老相关长链非编码RNA(SRlncRNA)特征,用于预测胶质瘤患者的总体生存期和肿瘤免疫微环境

Liu, Qing; Bao, Hongbo; Zhang, Sibin; Song, Tianjun; Li, Chenlong; Sun, Guiyin; Sun, Xiaoyang; Fu, Tianjiao; Wang, Yujie; Liang, Peng

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma

更正:开发免疫相关特征以预测胶质瘤患者的生存率和对免疫检查点抑制剂的反应

Zhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie; Liang, Peng

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma

开发一种免疫相关特征,用于预测胶质瘤患者的生存率和对免疫检查点抑制剂的反应

Zhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie; Liang, Peng

MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts.

MET 抑制剂卡马替尼通过抑制非小细胞肺癌中的 MET/Akt/snail 信号传导和减少癌症相关成纤维细胞的生成,克服了奥希替尼耐药性

Zhu Kaibin, Lv Zhonghua, Xiong Jinsheng, Zheng Hongshan, Zhang Sibin, Jin Hua, Yu Lei, Li Zhenzhe, Zhang Jixing, Li Chenlong, Liang Peng